{
    "xml": "<topic id=\"PHP34518\" outputclass=\"drugClass\" rev=\"1.26\" type=\"drugClass\" namespace=\"/drug-classes/vitamin-k-antagonists\" basename=\"vitamin-k-antagonists\" title=\"VITAMIN K ANTAGONISTS\">\n<title>VITAMIN K ANTAGONISTS</title>\n<topic id=\"PHP38741\" outputclass=\"contraindications\" rev=\"1.10\" parent=\"/drug-classes/vitamin-k-antagonists\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<p>\n<ph outputclass=\"contraindication\">Avoid use within 48 hours postpartum</ph>; <ph outputclass=\"contraindication\">haemorrhagic stroke</ph>; <ph outputclass=\"contraindication\">significant bleeding</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP38748\" outputclass=\"cautions\" rev=\"1.27\" parent=\"/drug-classes/vitamin-k-antagonists\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Bacterial endocarditis (use only if warfarin otherwise indicated)</ph>; <ph outputclass=\"caution\">conditions in which risk of bleeding is increased</ph>; <ph outputclass=\"caution\">history of gastrointestinal bleeding</ph>; <ph outputclass=\"caution\">peptic ulcer</ph>; <ph outputclass=\"caution\">postpartum (delay warfarin until risk of haemorrhage is low&#8212;usually 5&#8211;7 days after delivery)</ph>; <ph outputclass=\"caution\">recent ischaemic stroke</ph>; <ph outputclass=\"caution\">recent surgery</ph>; <ph outputclass=\"caution\">uncontrolled hypertension</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP38716\" outputclass=\"interactions\" rev=\"1.19\" parent=\"/drug-classes/vitamin-k-antagonists\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (coumarins, phenindione).</p>\n<p>Major changes in diet (especially involving salads and vegetables) and in alcohol consumption may affect warfarin control.</p>\n<p>Caution if concomitant use of drugs that increase risk of bleeding.</p>\n<p>Caution&#8212;avoid cranberry juice.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP38678\" outputclass=\"sideEffects\" rev=\"1.17\" parent=\"/drug-classes/vitamin-k-antagonists\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Alopecia</ph>; <ph outputclass=\"sideEffect\">diarrhoea</ph>; <ph outputclass=\"sideEffect\">haemorrhage</ph>; <ph outputclass=\"sideEffect\">hepatic dysfunction</ph>; <ph outputclass=\"sideEffect\">jaundice</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">pancreatitis</ph>; <ph outputclass=\"sideEffect\">purpura</ph>; <ph outputclass=\"sideEffect\">pyrexia</ph>; <ph outputclass=\"sideEffect\">rash</ph>; <ph outputclass=\"sideEffect\">skin necrosis (increased risk in patients with protein C or protein S deficiency)</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>; <ph outputclass=\"sideEffect\">&#8216;purple toes&#8217;</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP38744\" outputclass=\"conceptionAndContraception\" parent=\"/drug-classes/vitamin-k-antagonists\">\n<title>Conception and contraception</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Women of child-bearing age should be warned of the danger of teratogenicity.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP38710\" outputclass=\"pregnancy\" parent=\"/drug-classes/vitamin-k-antagonists\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Should not be given in the first trimester of pregnancy.</p>\n<p>Warfarin, acenocoumarol, and phenindione cross the placenta with risk of congenital malformations, and placental, fetal, or neonatal haemorrhage, especially during the last few weeks of pregnancy and at delivery. Therefore, if at all possible, they should be avoided in pregnancy, especially in the first and third trimesters (difficult decisions may have to be made, particularly in women with prosthetic heart valves, atrial fibrillation, or with a history of recurrent venous thrombosis or pulmonary embolism).</p>\n<p>Stopping these drugs before the sixth week of gestation may largely avoid the risk of fetal abnormality.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP38641\" outputclass=\"monitoringRequirements\" parent=\"/drug-classes/vitamin-k-antagonists\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>The base-line prothrombin time should be determined but the initial dose should not be delayed whilst awaiting the result.</p>\n<p>It is essential that the INR be determined daily or on alternate days in early days of treatment, <i>then</i> at longer intervals (depending on response), <i>then</i> up to every 12 weeks.</p>\n<p>Change in patient&#8217;s clinical condition, particularly associated with liver disease, intercurrent illness, or drug administration, necessitates more frequent testing.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP38703\" outputclass=\"patientAndCarerAdvice\" rev=\"1.36\" parent=\"/drug-classes/vitamin-k-antagonists\">\n<title>Patient and carer advice</title>\n<body>\r\n\r\n\r\n<section outputclass=\"patientResources\">\r\n<sectiondiv>\r\n<p outputclass=\"title\">Treatment Booklets</p>\r\n<p>Anticoagulant treatment booklets should be issued to all patients or their carers; these booklets include advice for patients on anticoagulant treatment, an alert card to be carried by the patient at all times, and a section for recording of INR results and dosage information. In <b>England</b>, <b>Wales</b>, and <b>Northern Ireland</b>, they are available for purchase from:</p>\r\n<ul outputclass=\"organization\">\r\n<li outputclass=\"thoroughfare\">Gorse Street, Chadderton</li>\r\n<li outputclass=\"thoroughfare\">Oldham</li>\r\n<li outputclass=\"postalcode\">OL9 9QH</li>\r\n<li outputclass=\"contactnumber\">Tel: 0845 610 1112</li>\r\n</ul>\r\n<p>GP practices can obtain supplies through their Local Area Team stores. NHS Trusts can order supplies from <xref format=\"html\" href=\"http://www.nhsforms.co.uk\">www.nhsforms.co.uk</xref>or by emailing nhsforms@mmm.com.</p>\r\n<p>In <b>Scotland</b>, treatment booklets and starter information packs can be obtained by emailing stockorders. dppas@theapsgroup.com or by fax on (0131) 6299 967</p>\r\n<p>Electronic copies of the booklets and further advice are also available at <xref format=\"html\" href=\"http://www.npsa.nhs.uk/nrls/alerts-and-directives/alerts/anticoagulant\">www.npsa.nhs.uk/nrls/alerts-and-directives/alerts/anticoagulant</xref>.</p>\n</sectiondiv>\n</section>\r\n\r\n\r\n\r\n\r\n\r\n\r\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugClasses\" href=\"#drugClasses\" title=\"Drug classes\" namespace=\"/drug-classes\">Drug classes</xref>\n</parents>\n<drugs>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP1494\" title=\"WARFARIN SODIUM\" namespace=\"/drugs/warfarin-sodium\">WARFARIN SODIUM</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP1499\" title=\"ACENOCOUMAROL\" namespace=\"/drugs/acenocoumarol\">ACENOCOUMAROL</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP1501\" title=\"PHENINDIONE\" namespace=\"/drugs/phenindione\">PHENINDIONE</xref>\n</drugs>\n<backlinks/>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"#drugClasses\" href=\"#drugClasses\" namespace=\"/drug-classes\" title=\"Drug classes\" count=\"1\" rel=\"link\">Drug classes</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP1494\" namespace=\"/drugs/warfarin-sodium\" title=\"WARFARIN SODIUM\" count=\"1\" rel=\"link\">WARFARIN SODIUM</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP1499\" namespace=\"/drugs/acenocoumarol\" title=\"ACENOCOUMAROL\" count=\"1\" rel=\"link\">ACENOCOUMAROL</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP1501\" namespace=\"/drugs/phenindione\" title=\"PHENINDIONE\" count=\"1\" rel=\"link\">PHENINDIONE</xref>\n</links>\n</topic>",
    "id": "PHP34518",
    "outputclass": "drugClass",
    "rev": "1.26",
    "type": "drugClass",
    "namespace": "/drug-classes/vitamin-k-antagonists",
    "basename": "vitamin-k-antagonists",
    "title": "VITAMIN K ANTAGONISTS",
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Avoid use within 48 hours postpartum",
                "html": "Avoid use within 48 hours postpartum"
            },
            {
                "type": "contraindications",
                "textContent": "haemorrhagic stroke",
                "html": "haemorrhagic stroke"
            },
            {
                "type": "contraindications",
                "textContent": "significant bleeding",
                "html": "significant bleeding"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Bacterial endocarditis (use only if warfarin otherwise indicated)",
                "html": "Bacterial endocarditis (use only if warfarin otherwise indicated)"
            },
            {
                "type": "cautions",
                "textContent": "conditions in which risk of bleeding is increased",
                "html": "conditions in which risk of bleeding is increased"
            },
            {
                "type": "cautions",
                "textContent": "history of gastrointestinal bleeding",
                "html": "history of gastrointestinal bleeding"
            },
            {
                "type": "cautions",
                "textContent": "peptic ulcer",
                "html": "peptic ulcer"
            },
            {
                "type": "cautions",
                "textContent": "postpartum (delay warfarin until risk of haemorrhage is low&#8212;usually 5&#8211;7 days after delivery)",
                "html": "postpartum (delay warfarin until risk of haemorrhage is low&#8212;usually 5&#8211;7 days after delivery)"
            },
            {
                "type": "cautions",
                "textContent": "recent ischaemic stroke",
                "html": "recent ischaemic stroke"
            },
            {
                "type": "cautions",
                "textContent": "recent surgery",
                "html": "recent surgery"
            },
            {
                "type": "cautions",
                "textContent": "uncontrolled hypertension",
                "html": "uncontrolled hypertension"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (coumarins, phenindione).\n\nMajor changes in diet (especially involving salads and vegetables) and in alcohol consumption may affect warfarin control.\n\nCaution if concomitant use of drugs that increase risk of bleeding.\n\nCaution&#8212;avoid cranberry juice.",
                "html": "<p>Appendix 1 (coumarins, phenindione).</p><p>Major changes in diet (especially involving salads and vegetables) and in alcohol consumption may affect warfarin control.</p><p>Caution if concomitant use of drugs that increase risk of bleeding.</p><p>Caution&#8212;avoid cranberry juice.</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Alopecia",
                        "html": "Alopecia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "diarrhoea",
                        "html": "diarrhoea",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "haemorrhage",
                        "html": "haemorrhage",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hepatic dysfunction",
                        "html": "hepatic dysfunction",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "jaundice",
                        "html": "jaundice",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "pancreatitis",
                        "html": "pancreatitis",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "purpura",
                        "html": "purpura",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "pyrexia",
                        "html": "pyrexia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "rash",
                        "html": "rash",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "skin necrosis (increased risk in patients with protein C or protein S deficiency)",
                        "html": "skin necrosis (increased risk in patients with protein C or protein S deficiency)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "&#8216;purple toes&#8217;",
                        "html": "&#8216;purple toes&#8217;",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        }
    },
    "conceptionAndContraception": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Women of child-bearing age should be warned of the danger of teratogenicity.",
                "html": "<p>Women of child-bearing age should be warned of the danger of teratogenicity.</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Should not be given in the first trimester of pregnancy.\n\nWarfarin, acenocoumarol, and phenindione cross the placenta with risk of congenital malformations, and placental, fetal, or neonatal haemorrhage, especially during the last few weeks of pregnancy and at delivery. Therefore, if at all possible, they should be avoided in pregnancy, especially in the first and third trimesters (difficult decisions may have to be made, particularly in women with prosthetic heart valves, atrial fibrillation, or with a history of recurrent venous thrombosis or pulmonary embolism).\n\nStopping these drugs before the sixth week of gestation may largely avoid the risk of fetal abnormality.",
                "html": "<p>Should not be given in the first trimester of pregnancy.</p><p>Warfarin, acenocoumarol, and phenindione cross the placenta with risk of congenital malformations, and placental, fetal, or neonatal haemorrhage, especially during the last few weeks of pregnancy and at delivery. Therefore, if at all possible, they should be avoided in pregnancy, especially in the first and third trimesters (difficult decisions may have to be made, particularly in women with prosthetic heart valves, atrial fibrillation, or with a history of recurrent venous thrombosis or pulmonary embolism).</p><p>Stopping these drugs before the sixth week of gestation may largely avoid the risk of fetal abnormality.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "The base-line prothrombin time should be determined but the initial dose should not be delayed whilst awaiting the result.\n\nIt is essential that the INR be determined daily or on alternate days in early days of treatment, then at longer intervals (depending on response), then up to every 12 weeks.\n\nChange in patient&#8217;s clinical condition, particularly associated with liver disease, intercurrent illness, or drug administration, necessitates more frequent testing.",
                "html": "<p>The base-line prothrombin time should be determined but the initial dose should not be delayed whilst awaiting the result.</p><p>It is essential that the INR be determined daily or on alternate days in early days of treatment, <i>then</i> at longer intervals (depending on response), <i>then</i> up to every 12 weeks.</p><p>Change in patient&#8217;s clinical condition, particularly associated with liver disease, intercurrent illness, or drug administration, necessitates more frequent testing.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "patientResources": [
            {
                "type": "patientResources",
                "references": [
                    {
                        "id": "http://www.nhsforms.co.uk",
                        "label": "www.nhsforms.co.uk"
                    },
                    {
                        "id": "http://www.npsa.nhs.uk/nrls/alerts-and-directives/alerts/anticoagulant",
                        "label": "www.npsa.nhs.uk/nrls/alerts-and-directives/alerts/anticoagulant"
                    }
                ],
                "title": "Treatment Booklets",
                "textContent": "Anticoagulant treatment booklets should be issued to all patients or their carers; these booklets include advice for patients on anticoagulant treatment, an alert card to be carried by the patient at all times, and a section for recording of INR results and dosage information. In England, Wales, and Northern Ireland, they are available for purchase from:\n\nGorse Street, Chadderton Oldham OL9 9QH Tel: 0845 610 1112\n\nGP practices can obtain supplies through their Local Area Team stores. NHS Trusts can order supplies from www.nhsforms.co.ukor by emailing nhsforms@mmm.com.\n\nIn Scotland, treatment booklets and starter information packs can be obtained by emailing stockorders. dppas@theapsgroup.com or by fax on (0131) 6299 967\n\nElectronic copies of the booklets and further advice are also available at www.npsa.nhs.uk/nrls/alerts-and-directives/alerts/anticoagulant.",
                "html": "<p>Anticoagulant treatment booklets should be issued to all patients or their carers; these booklets include advice for patients on anticoagulant treatment, an alert card to be carried by the patient at all times, and a section for recording of INR results and dosage information. In <b>England</b>, <b>Wales</b>, and <b>Northern Ireland</b>, they are available for purchase from:</p><ul outputclass=\"organization\">\r\n<li outputclass=\"thoroughfare\">Gorse Street, Chadderton</li>\r\n<li outputclass=\"thoroughfare\">Oldham</li>\r\n<li outputclass=\"postalcode\">OL9 9QH</li>\r\n<li outputclass=\"contactnumber\">Tel: 0845 610 1112</li>\r\n</ul><p>GP practices can obtain supplies through their Local Area Team stores. NHS Trusts can order supplies from <xref format=\"html\" href=\"http://www.nhsforms.co.uk\">www.nhsforms.co.uk</xref>or by emailing nhsforms@mmm.com.</p><p>In <b>Scotland</b>, treatment booklets and starter information packs can be obtained by emailing stockorders. dppas@theapsgroup.com or by fax on (0131) 6299 967</p><p>Electronic copies of the booklets and further advice are also available at <xref format=\"html\" href=\"http://www.npsa.nhs.uk/nrls/alerts-and-directives/alerts/anticoagulant\">www.npsa.nhs.uk/nrls/alerts-and-directives/alerts/anticoagulant</xref>.</p>"
            }
        ]
    },
    "drugsInClass": [
        {
            "id": "PHP1494",
            "label": "WARFARIN SODIUM",
            "type": "drug"
        },
        {
            "id": "PHP1499",
            "label": "ACENOCOUMAROL",
            "type": "drug"
        },
        {
            "id": "PHP1501",
            "label": "PHENINDIONE",
            "type": "drug"
        }
    ],
    "backlinks": {},
    "links": {
        "#drugClasses": [
            {
                "id": "drugClasses",
                "label": "Drug classes",
                "type": "#drugClasses"
            }
        ],
        "drug": [
            {
                "id": "PHP1494",
                "label": "WARFARIN SODIUM",
                "type": "drug"
            },
            {
                "id": "PHP1499",
                "label": "ACENOCOUMAROL",
                "type": "drug"
            },
            {
                "id": "PHP1501",
                "label": "PHENINDIONE",
                "type": "drug"
            }
        ]
    }
}